Adeno-Associated Virus Neutralizing Antibodies in Large Animals and Their Impact on Brain Intraparenchymal Gene Transfer-Reference-Cited by-同舟云学术

Adeno-Associated Virus Neutralizing Antibodies in Large Animals and Their Impact on Brain Intraparenchymal Gene Transfer

Published:2018-12 Issue: Volume:11 Page:65-72
ISSN:2329-0501
Container-title:Molecular Therapy - Methods & Clinical Development
language:en
Short-container-title:Molecular Therapy - Methods & Clinical Development

Author:

Wang Dan,Zhong Li,Li Mengxin,Li Jia,Tran Karen,Ren Lingzhi,He Ran,Xie Jun,Moser Richard P.,Fraser Cara,Kuchel Tim,Sena-Esteves Miguel,Flotte Terence R.,Aronin Neil,Gao Guangping

Funder

CHDI Foundation

Publisher

Elsevier BV

Subject

Genetics,Molecular Biology,Molecular Medicine

Reference38 articles.

1. Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response;Manno;Nat. Med.,2006

2. Unraveling the Complex Story of Immune Responses to AAV Vectors Trial After Trial;Vandamme;Hum. Gene Ther.,2017

3. Overcoming the Host Immune Response to Adeno-Associated Virus Gene Delivery Vectors: The Race Between Clearance, Tolerance, Neutralization, and Escape;Mingozzi;Annu. Rev. Virol.,2017

4. Pre-existing anti-adeno-associated virus antibodies as a challenge in AAV gene therapy;Louis Jeune;Hum. Gene Ther. Methods,2013

5. Worldwide epidemiology of neutralizing antibodies to adeno-associated viruses;Calcedo;J. Infect. Dis.,2009

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neurosurgical gene therapy for central nervous system diseases;Neurotherapeutics;2024-07

2. Immune responses to central nervous system directed adeno-associated virus gene therapy: Does direct CNS delivery make a difference?;Neurotherapeutics;2024-07

3. Adeno-associated virus as a delivery vector for gene therapy of human diseases;Signal Transduction and Targeted Therapy;2024-04-03

4. Taking the knife to neurodegeneration: a review of surgical gene therapy delivery to the CNS;Acta Neurochirurgica;2024-03-14

5. Preexisting antibody assays for gene therapy: Considerations on patient selection cutoffs and companion diagnostic requirements;Molecular Therapy - Methods & Clinical Development;2024-03